Цель. Изучить изменение уровня сосудистого эндотелиального фактора роста (VEGF) и частоту рецидива варикозно-го расширения вен после стандартной флебэктомии и гибридного лечения. Материалы и методы. В исследование включили 134 пациента, которых разделили на две группы в зависимости от метода лечения. Флебэктомию выполняли по стандартной методике. Гибридное лечение включало лазерную абляцию, ультразвуковую пенообразующую склеротерапию (этоксисклерол 1-3%), высокую степень лигирования, полное или частичное удаление подкожной вены. Лечение было индивидуальным для каждого пациента. Образцы сыворотки от-бирали у пациентов до и через 3-12 мес после операции. Контрольную группу составили 20 здоровых лиц. Проанали-зированы изменения уровня VEGF в сыворотке крови пациентов до и после лечения. Результаты. Средний уровень VEGF снизился в 3,95 -5,38 раза после лечения. У пациентов, у которых возник рецидив варикозного расширения вен, уровни VEGF были выше, чем у остальных пациентов. Выводы. Результаты исследования позволяют предположить наличие связи между рецидивом варикозного расшире-ния вен и изменением уровня VEGF. Ключевые слова: варикозное расширение вен; неоваскуляризация; флебэктомия; гибридное лечение; сосудистый эн-дотелиальный фактор роста.
Introduction
Chronic venous insufficiency (CVI) is widely spread pathology. Symptoms of CVI can be found in 25-27% of women and 15% of men in adult population [1] [2] . It affects 33 million patients over 40 years old (11 million men and 22 million women) in the USA [3] . Despite the great progress in treatment, signs of the recurrence and progression of varicose veins (VV) can be diagnosed at 21-23% of patients [4] .
There are 3 general types of recurrence of VVs [5] : 1) Residual VV, (that can be found in operation area during one month or later in post operative period).
2) True recurrent VV: that appears after one month in post operative period due to neovascularization or wrong management strategy.
3) New VV, that were absent before surgery and appeared because of the disease progression [5] .
Many researches mark a neovascularization or neoangiogenesis as a major reason of VV recurrence [5] . Traditionally, many surgeons believe, that the recurrence can be prevented by an adequately performed operation. Several works have questioned the traditional view. Researchers found newly formed vessels in the inguinal area of patients after ligation and stripping of great saphenous vein (GSV). This was documented by ultra sound doplerography and phlebography [6] . But results of other studies show that neovascularization appeared in a relatively small group of patients with recurrent VV. The recurrence was mostly related to an inadequate surgery and progression of the disease [7] . In fact, these statements do not always contradict to each other. Neovascularization can appear after a properly performed operation. On the other hand, the incompetence of sapheno-femoral junction (SFJ) or untreated GSV forms favorable conditions for the formation of the recurrent reflux [8] .
Neovascularization can cause a reappearance of VV in 2 different ways:
1) Due to the enlarging of small venous branches between deep and superficial veins.
2) Due to the creation of new vessels that reconnects basin of deep and superficial veins [7, 9] .
An important protagonist of neovascularization and angiogenesis, so called "vascular endothelial growth factor" (VEGF) was determined in 1989 by N. Ferrara, W. I. Herzel [10] . In further studies, elevated level of VEGF has been found in serum, plasma and epidermis of patients with VV [11] [12] [13] [14] .
VEGF has dual roles in organism. On the one hand, it is necessary for the stability of the endothelium and for the physiological neoangiogenesis. On the other hand, VEGF plays a leading role in the pathogenesis of oncologic diseases. VEGF is a pro-inflammatory cytokine that induces the activity of macrophages and endothelium [15] . Therefore, VEGF is necessary for the maintenance of vascular integrity and reactivity [16] . The presence of VEGF is established in the epidermis of patients with chronic venous insufficiency (CVI). Also the high level of VEGF is found in blood plasma which increases during the progression of the disease [17] . Similarly, an increase in the expression of the VEGF gene in VV is clearly associated with an incompetence of SFJ. It is considered that VEGF is induced in patients with VV to repair tissue damage caused by venous hypertension [18] .
Despite the large number of patients with varicose veins, there is no general consensus on treatment strategy [19] . This is why to achieve better clinical results treatment strategy should be personalized.
Methods

Selection criteria
Patients with primary varicose veins of C2, C3and C4 class according to CEAP classification were included into the study. All patients were over 18 years of age.
Exclusion criteria was following: any operations, injuries or infection 30 days before the study, blood disorders, diabetes mellitus, arterial disease (ankle-brachial index, 0.9), impaired renal or hepatic function, deep venous thrombosis (less than 1 year), pregnant or lactating women, skin ulcers, benign or malignant tumors of any localization.
Before the operation, the following studies were performed: ECG, Chest x-ray, ultrasound doplerography of veins, common blood count, urine test, biochemical blood test, coagullogram.
The diagnosis of primary or recurrent varicose vein was performed by the clinical examination and ultra sound investigation (USI) of veins.
The presence of dilated veins, varices, pathological reflux or telangiectasias was counted as signs of primary or recurrent VV. During the USI we paid attention to the consistency and the structure of walls, compressibility of veins, function of venous valves, phases of venous flow, and presence of color filling defect, reflux or any flow disturbances. We also performed a Valsalva manoeuvre, manual distal augmentation, and plantar-flexion to check calf muscle pump.
Ethical approval for this study was given by ethical committee of the Astana Medical University. Therefore study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All patients have signed an informed consent form.
Methods of operation
In this work we used following methods of treatment: 1. Conventional phlebectomy (CP) included high ligation, saphenous trunk stripping, ligation of perforator veins, removing of dilated tributary veins. 2. Hybrid treatment (H) consisted of combination of methods, including laser ablation, ultrasound guided foam form sclerotherapy (aethoxysklerol 1-3%), high ligation (HL), total or partial stripping of saphenous vein. The treatment was personalized to every patient. Different combinations of listed methods were applied depending on clinical stage, diameter of veins, severity of reflux, and localization of VV's.
Conventional phlebectomy is a combination of several operations, such as high ligation, GSV stripping, also known as a Babcock's operation, supra-or subfascial ligation of perforator veins, and removing of dilated tributary veins [20, 21] Klinichna khirurhiia Therefore, to designate a combination of endovenous and open methods of surgery, we used the term hybrid treatment.
Conventional phlebectomy was known as the gold standard of treatment for varicose veins [20] This is why results of hybrid group were compared to results of CP. After initial assessment 124 patients were included in the study, a total 248 samples were studied. All patients were divided into two groups depending on the method of operation ( Table 1) . There was no difference in the mean age and gender distribution between study groups. The first group included 66 patients, treated with the conventional phlebectomy. This group is marked as CP. The second group consists of 58 patients, treated with hybrid method. This group is marked as H. Serum samples of twenty healthy volunteers were studied in a control group.
Serum sampling
Serum samples were collected from patients before operation and 3-12 month after operation. In this period first symptoms of recurrence or progression of the disease can be found. Blood samples were taken into vacuum test-tubes and then centrifuged at 3500 rpm for 10 minutes. Samples were stored at -20°C until the test. In our experiment ELISA test was conducted using a commercially available kit (Thermo Scientific 7335 Executive Way Frederick, MD 21704), according to manufacturer's specification. Samples were defrosted at +20-+25°С prior to the experiment.
Statistical analysis
Data are expressed as mean, Stata software was used for statistical analyses. Student's t-test was used to compare between the means. Differences were considered statistically significant at p < 0.05. To find the connection between the treatment method and VEGF level Pearson's correlation coefficient (r) was calculated.
Results
After conducting the experiment on the determination of VEGF level in serum of patients with varicose veins, we reached the following results.
Serum VEGF levels have a significant difference before and after treatment (Fig. 1) . As we can see in CP group the mean level of serum VEGF before operation was 104.16 pg/ ml, whereas after operation it decreased 3.95 times and equals to 26.39 pg/ml (p < 0.05, r=0.782). Mean concentration of VEGF in hybrid group decreased 3.95 times, from 72.74 pg/ml before operation to 13.5 pg/ml after the treatment (p < 0.05, r=0.252) There is a direct correlation between the treatment and level of VEGF change study groups.
In case of the recurrence VEGF level was higher compared to non-recurrent cases. Also in recurrent cases VEGF level did not fell lower than 62.5 pg/ml (p < 0.05). In control group mean level of VEGF was 24.21 pg/ml.
There was no recurrence after operation if patient's level of VEGF was lower than 62.5pg/ml. Taking into account that in control group maximal level of VEGF was 31.25 pg/ml, we considered the range from 7.8 to 31.25 as a normal level of VEGF and if the range of VEGF level was higher than 62.5 pg/ ml we considered it as a high level. Thus, we calculated numbers of patient with normal and high level of VEGF and analyzed the change of VEGF level before and after treatment (Fig. 2, 3) .
The number of samples with high level of VEGF has decreased after the treatment. According to the results before conventional phlebectomy 39 patients showed high level of VEGF and 27 showed normal level, whereas after operation number of patient with elevated level of VEGF were equal to 5. In hybrid group the high VEGF level were found in 37 patients before operation and only in 3 patients after operation. Thus, the number of samples with normal VEGF level has increased after the treatment. We analyzed number of recurrence of varicose veins ( Table  2) . After the conventional phlebectomy we found 7.57% cases of recurrences. In hybrid group 5.17% of patients showed signs of recurrence.
Speaking about the types of recurrence: of VV for CP group 3.03% of cases were connected to technical or tactical mistakes. In these cases the recurrence occurred due to unligated GSV tributaries, especially in SFJ area as well as incomplete removing of GSV trunk or/and its branches. The true recurrent VV appeared in 3.03% of cases. New VV were observed in 1.51% of cases. These cases were presented by appearance of small tortuous venous branches or/and telangiectasias.
For hybrid group technical or tactical mistakes were found in 1.72 % of cases. In this case the recurrence happened due to recanalisation of GSV branches treated with foam form sclerotherapy. The number of recurrence related to the true recurrent VV and newly formed VV was found in 1.72% of cases. These cases were presented by appearance of telangiectasias (Table 3) 
Conclusions
After conducting the experiment on determination of VEGF level in serum of patients with varicose veins, we made the following conclusions:
-The mean level of serum VEGF in the study groups has a wide variation range. In CP groups the mean level of serum VEGF decreased 3.95 times after the treatment. The mean concentration of VEGF in hybrid group decreased 5.38 times. The observed differences are statistically significant (significance level p <0.05).
-The level of serum VEGF in study groups before and after operation has a direct correlation.
-In case of the recurrence, VEGF level were higher than in non-recurrent cases. Also in recurrent cases VEGF level did not fell lower than 62.5 pg/ml.
-Results of the study suggest an association between recurrence of varicose veins and change of VEGF level.
-Not only the technical and tactical mistakes can lead to the recurrence of VV, but also the process of neovascularization plays important role.
Discussion
The formation of new vessels after operation as a result of neovascularization has been described in previous works [22] . On the base of our results we can say that recurrence can appear even after properly performed surgery. Support to this statement can be found in the work of A. M. van Rij et al [23] . According to literature, the recurrence related to neovascularization happens in 8-60% of cases [22, 24] . Some studies revealed that there is a connection between VV and changes in VEGF level [14] . This is why we were interested to study how VEGF levels change after conventional phlebectomy and hybrid method of treatment.
After the conventional phlebectomy, new vessels are formed due to the ligation of vessels and tissue damage resulting in hypoxia [25] . This leads to the release of VEGF [26] . After the endovenous interventions damage of the endothelium may trigger the release of the VEGF. Benefits of the hybrid treatment are that it may help to avoid disadvantages of different methods of intervention. In hybrid group we had a lower recurrence rate comparing to CP group, but this didn't reach statistical significance.
We compared results of our study to the results of similar researches. In study of Florez et al. authors included 84 subjects, 44 with CVI and 40 controls. They found a prominent expression of VEGF in the VV of the CVI group than in the control group with healthy subjects [14] .
In study researchers analyzed blood samples of 30 patients with primary VVs undergoing treatment with EVLA before and 1 week after operation [27] . Control group included 20 healthy persons. They found statistically significant reduction in median plasma VEGF levels before operation and rise of its level in 1 week after surgery. In our study we also found cases of normal or comparably low VEGF level in preoperative period, but after operation it decreased multiple times. We didn't find any elevation of VEGF after operation comparing to the pre-operative period. In our opinion this is connected to the period of taking of control samples. We believe rise of VEGF levels 1 week after operation in study can be connected to healing processes, as neovascularization of damaged tissue is a necessary part of healing [27, 28] . This is why we excluded any operations, injuries or infection 30 days before the study. Yasin et al studied VEGF level of 25 patients with primary varicose veins and compared the results with 25 healthy persons. Plasma VEGF level was significantly higher in patients with varicose veins than in healthy persons [13] . This results correlate with our study, as we also found high levels of serum VEGF before treatment and decreasing of VEGF level after the treatment.
As we can see, there are studies that analyzed the relationship between VVs and VEGF. But we didn't find any studies that compared results of conventional phlebectomy with the results of hybrid treatment. According to the results of our study not only surgeon's mistakes leads to the recurrence, but also the process of neovascularization itself plays an important role in reccurence and progression of the disease. This kind of the information may help to protect surgeons in controversial cases. Further studies of this field in a larger group may lead to better understanding of the pathogenesis of the recurrence and discovering of new antiangiogenic therapy strategies in future.
